These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin. Matsuoka M, Kashiwabara Y, Namisato M. Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288 [Abstract] [Full Text] [Related]
4. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines. Matsuoka M, Budiawan T, Aye KS, Kyaw K, Tan EV, Cruz ED, Gelber R, Saunderson P, Balagon V, Pannikar V. Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708 [Abstract] [Full Text] [Related]
5. [Multi-drug resistant Mycobacterium leprae from patients with leprosy]. Maeda S. Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725 [Abstract] [Full Text] [Related]
6. Drug resistance in Mycobacterium leprae from patients with leprosy in China. Liu D, Zhang Q, Sun Y, Wang C, Zhang Y, Fu X, Chen M, Zhou G, Yu X, Wang J, Liu H, Zhang F. Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507 [Abstract] [Full Text] [Related]
10. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy. Sekar B, Arunagiri K, Kumar BN, Narayanan S, Menaka K, Oommen PK. Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470 [Abstract] [Full Text] [Related]
12. Structural Implications of Mutations Conferring Rifampin Resistance in Mycobacterium leprae. Vedithi SC, Malhotra S, Das M, Daniel S, Kishore N, George A, Arumugam S, Rajan L, Ebenezer M, Ascher DB, Arnold E, Blundell TL. Sci Rep; 2018 Mar 22; 8(1):5016. PubMed ID: 29567948 [Abstract] [Full Text] [Related]
13. qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. Araujo S, Goulart LR, Truman RW, Goulart IMB, Vissa V, Li W, Matsuoka M, Suffys P, Fontes AB, Rosa PS, Scollard DM, Williams DL. PLoS Negl Trop Dis; 2017 Jun 22; 11(6):e0005506. PubMed ID: 28570560 [Abstract] [Full Text] [Related]
14. Is drug-resistant Mycobacterium leprae a real cause for concern?: First approach to molecular monitoring of multibacillary Colombian patients with and without previous leprosy treatment. Guerrero MI, Colorado CL, Torres JF, León CI. Biomedica; 2014 Apr 22; 34 Suppl 1():137-47. PubMed ID: 24968045 [Abstract] [Full Text] [Related]
15. Drug-resistant leprosy: monitoring and current status. Williams DL, Gillis TP. Lepr Rev; 2012 Sep 22; 83(3):269-81. PubMed ID: 23356028 [No Abstract] [Full Text] [Related]
16. Evidence for Mycobacterium leprae Drug Resistance in a Large Cohort of Leprous Neuropathy Patients from India. Mahajan NP, Lavania M, Singh I, Nashi S, Preethish-Kumar V, Vengalil S, Polavarapu K, Pradeep-Chandra-Reddy C, Keerthipriya M, Mahadevan A, Yasha TC, Nandeesh BN, Gnanakumar K, Parry GJ, Sengupta U, Nalini A. Am J Trop Med Hyg; 2020 Mar 22; 102(3):547-552. PubMed ID: 31933458 [Abstract] [Full Text] [Related]
17. Drug resistance in leprosy: lessons from past and future perspective. Gupta UD, Katoch VM. Indian J Lepr; 1999 Mar 22; 71(4):451-63. PubMed ID: 10804973 [Abstract] [Full Text] [Related]
18. Single-dose treatment for paucibacillary leprosy; feasibility of long-term follow up. Ganapati R, Revankar CR, Pai VV, Kingsley S. Int J Lepr Other Mycobact Dis; 1999 Sep 22; 67(3):308-9. PubMed ID: 10575413 [No Abstract] [Full Text] [Related]
19. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients. Lavania M, Singh I, Turankar RP, Ahuja M, Pathak V, Sengupta U, Das L, Kumar A, Darlong J, Nathan R, Maseey A. J Glob Antimicrob Resist; 2018 Mar 22; 12():214-219. PubMed ID: 29097343 [Abstract] [Full Text] [Related]